Neuroprotective and toxic changes in microglia in neurodegenerative disease

Parkinsonism and Related Disorders

Volumn 15, Issue 1, 2009, Pages

  Sawada, Makoto ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

HIV Nef; Microglia; ROS; Toxic transformation

Indexed keywords

ANIMALS; GENE PRODUCTS, NEF; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES; REACTIVE OXYGEN SPECIES;

EID: 58149141584     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70011-2     Document Type: Article

References (13)

1. Dexter D.T., Nanayakkara I., Goss-Sampson M.A., Muller D.P., Harding A.E., Marsden C.D., et al. Nigral dopaminergic cell loss in vitamin E deficient rats. Neuroreport 5 (1994) 1773-1776
2. Nagatsu T., and Sawada M. Cellular and molecular mechanisms of Parkinson's disease: Neurotoxins, causative genes, and inflammatory cytokines. Cell Mol Neurobiol 26 (2006) 781-802
3. Sawada M., Imamura K., and Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transmembr Suppl (2006) 373-381
4. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., and Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol 106 (2003) 518-526
5. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., et al. Blockade of microglial activation is neuroprotective in the 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22 (2002) 1763-1771
6. Wu D.C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., et al. NADPH oxidase mediates oxidative stress in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson disease. Proc Natl Acad Sci USA 100 (2003) 6145-6150
7. Furuya T., Hayakawa H., Yamada M., Yoshimi K., Hisahara S., Miura M., et al. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 24 (2004) 1865-1872
8. Sawada M., Suzumura A., and Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13 (1995) 253-264
9. Ito S., Sawada M., Haneda M., and Ishida Y. Isobe. Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via PI3K/Akt and/or ERK pathway. Neurosci Res 56 (2006) 294-299
10. Sawada H., Hashida R., Hirata Y., Ono K., Suzuki H., Muramatsu S.I., et al. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl- 1,2,3,6-tetra-hydropyridine. J Neurosci Res 85 (2007) 1752-1761
11. Imai F., Suzuki H., Oda J., Ninomiya T., Ono K., Sano H., et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cerebral Blood Flow Metab 27 (2007) 488-500
12. Sankarapandi S., Zweier J.L., Mukherjee G., Quinn M.T., and Huso D.L. Measurement and characterization of superoxide generation in microglial cells: evidene for an NADPH oxidase-dependent pathway. Arch Biochem Biophys 353 (1998) 312-321
13. Vilhardt F., Plastre O., Sawada M., Suzuki K., Wiznerowicz M., Kiyokawa E., et al. The HIV-1 Nef protein and phagocyte NADPH oxidase activation. J Biol Chem 277 (2002) 42136-42143